Pharmaceutical biotechnology in the post-genomic era
- In: S2 - Pharmaceutical biotechnology in the post-genomic era on Tuesday, 6 September 2005, 9:00-17:00
- At: Cairo (Egypt) (2005)
- Type: Presentation
- By: CROMMELIN, Daan (Utrecht University, Pharmaceutics, Utrecht, Netherlands)
Pharmaceutical proteins are large, often physically and chemically unstable molecules. These characteristics lead to two special features typical for these molecules: 1) formulating proteins (assessment of quality, selection of dosage form, stability) is a complicated matter, 2) the predominant route of administration is the parenteral route... The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.